Comparison of Geospatial Differences in Pharmaceutical Company Payments to Physicians and Target Patient Populations for GLP-1 and Dual GLP-1/GIP Receptor Agonist Drugs

Program Number: P09-48
R. S. Anderson, NextGenPop/University of California, Los Angeles.

More in this Session